Galderma's agreement to buy ZO Skin Health
A:Yes, Galderma signed an agreement on October 14, 2026 to buy 100% of ZO Skin Health for an enterprise value of $1.5 billion in an all-cash deal. The deal is expected to close in the fourth quarter of 2026 or early 2027, subject to regulatory approvals and other customary closing conditions. Galderma is buying from shareholders that include funds managed by Blackstone and the Obagi family, who founded ZO Skin Health.1
ZO Skin Health sells over 40 products through more than 16,500 physician, medical spa, and online accounts, so many practices already stock the brand Galderma is buying. Galderma says ZO's retinol- and acid-based daily regimens complement Alastin's peptide-based pre- and post-procedure line.1 Kline + Co. reported that ZO and Alastin together will give Galderma a 19% share of the U.S. medical care provider skincare channel.2
Galderma plans to increase commercial investment during the first year of ownership to build a foundation for renewed growth beginning in the second year after closing.1 On our reading, practices that sell ZO should expect the brand's commercial support to shift under Galderma once the deal closes. For more about what the deal could mean for practices, see our ZO retail shelf.
Notice
This article is for informational purposes only. It describes published sources and gives our opinion on what they mean for running a practice. It is not medical or legal advice, it does not create a doctor‑patient or attorney‑client relationship, and it should not be used to make any medical or legal decision. Discuss treatment with a qualified healthcare provider and legal questions with a licensed attorney. What it says about any company, product, or pharmacy comes from the sources cited below, and anything beyond them is our opinion. To report an error, email lazar@fractionalaesthetics.com and we will review it.
How patients see your practice
The FAx audit scores what a prospective patient sees: search, reviews, presence, and AI. It takes two minutes to request and needs no call, and the audit arrives by email within a couple of business days, yours to keep.
More market research
Sofwave usage fees rose 60% in one quarter. What does Sofwave tell investors about practice margins?Sofwave's usage fees rose 60% to $13.3 million in Q3 2026.5 min read About half of body contouring patients were ready at a PA or NP visit. When do the rest return?A PA or nurse practitioner found about half of body contouring patients ready.7 min read Juvéderm sales fell 11.8% year over year. How often do toxin patients add filler?In 2025, 13% of US toxin treatments came with a filler treatment, down from about 21% in 2017.5 min readReferences (2)
- Galderma, Galderma Signs Agreement to Acquire ZO Skin Health, Strengthening Its Physician-Dispensed Skincare Offering, 2026. Vendor-published. https://investors.galderma.com/news-releases/news-release-details/galderma-signs-agreement-acquire-zo-skin-health-strengthening Back to where you were ↑
- Beauty Independent, Galderma Bolsters Its Skincare-To-Syringes Portfolio With $1.5B Deal For ZO Skin Health, 2026. Trade press. https://www.beautyindependent.com/galderma-bolsters-skincare-portfolio-1-5b-deal-zo-skin-health/ Back to where you were ↑